Literature DB >> 23919773

Elevated Aβ42 in aged, non-demented individuals with cerebral atherosclerosis.

Katherine R Sadleir1, David A Bennett, Julie A Schneider, Robert Vassar.   

Abstract

The β-secretase, BACE1, generates β-amyloid (Aβ), a major hallmark of Alzheimer's disease (AD) pathology. The elevation of BACE1 levels in brains of AD patients may play a role in initiating or propagating disease. BACE1 levels are increased under low energy or low oxygen conditions, which may occur in individuals with impaired circulation in the brain. We compared levels of BACE1 in the brains of aged, non-demented individuals with high or low levels of atherosclerosis in the circle of Willis, and found that while there is no change in BACE1, Aβ42 levels are elevated in the high atherosclerosis group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23919773      PMCID: PMC4041148          DOI: 10.2174/15672050113109990152

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  28 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles.

Authors:  Thomas G Beach; Jeffrey R Wilson; Lucia I Sue; Amanda Newell; Marissa Poston; Raquel Cisneros; Yoga Pandya; Chera Esh; Donald J Connor; Marwan Sabbagh; Douglas G Walker; Alex E Roher
Journal:  Acta Neuropathol       Date:  2006-09-20       Impact factor: 17.088

3.  Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.

Authors:  Alex E Roher; Suzanne L Tyas; Chera L Maarouf; Ian D Daugs; Tyler A Kokjohn; Mark R Emmerling; Zsolt Garami; Marek Belohlavek; Marwan N Sabbagh; Lucia I Sue; Thomas G Beach
Journal:  Alzheimers Dement       Date:  2011-03-09       Impact factor: 21.566

Review 4.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

5.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

6.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Increased beta-secretase activity and expression in rats following transient cerebral ischemia.

Authors:  Yi Wen; Otuonye Onyewuchi; Shaohua Yang; Ran Liu; James W Simpkins
Journal:  Brain Res       Date:  2004-05-29       Impact factor: 3.252

8.  Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

Authors:  Oda-Christina Suter; Thanomphone Sunthorn; Rudolf Kraftsik; Joel Straubel; Pushpa Darekar; Kamel Khalili; Judith Miklossy
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

9.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

10.  Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans.

Authors:  Henrik Zetterberg; Erik Mörtberg; Linan Song; Lei Chang; Gail K Provuncher; Purvish P Patel; Evan Ferrell; David R Fournier; Cheuk W Kan; Todd G Campbell; Ray Meyer; Andrew J Rivnak; Brian A Pink; Kaitlin A Minnehan; Tomasz Piech; David M Rissin; David C Duffy; Sten Rubertsson; David H Wilson; Kaj Blennow
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more
  9 in total

Review 1.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Authors:  Costantino Iadecola; Marco Duering; Vladimir Hachinski; Anne Joutel; Sarah T Pendlebury; Julie A Schneider; Martin Dichgans
Journal:  J Am Coll Cardiol       Date:  2019-07-02       Impact factor: 24.094

Review 2.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 3.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease.

Authors:  Ajay Gupta; Costantino Iadecola
Journal:  Front Aging Neurosci       Date:  2015-06-16       Impact factor: 5.750

5.  Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.

Authors:  Katherine R Sadleir; William A Eimer; Sarah L Cole; Robert Vassar
Journal:  Mol Neurodegener       Date:  2015-01-07       Impact factor: 14.195

6.  BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology.

Authors:  Finn Peters; Hazal Salihoglu; Eva Rodrigues; Etienne Herzog; Tanja Blume; Severin Filser; Mario Dorostkar; Derya R Shimshek; Nils Brose; Ulf Neumann; Jochen Herms
Journal:  Acta Neuropathol       Date:  2018-01-11       Impact factor: 17.088

7.  ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Katherine R Sadleir; Jelena Popovic; Robert Vassar
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

8.  Differential Expression Patterns of Lynx Proteins and Involvement of Lynx1 in Prepulse Inhibition.

Authors:  Yasmine Sherafat; Edison Chen; Valeria Lallai; Malia Bautista; James P Fowler; Yen-Chu Chen; Julie Miwa; Christie D Fowler
Journal:  Front Behav Neurosci       Date:  2021-11-03       Impact factor: 3.558

9.  Deterioration of cognitive function after transient cerebral ischemia with amyloid-β infusion-possible amelioration of cognitive function by AT2 receptor activation.

Authors:  Li-Juan Min; Jun Iwanami; Masachika Shudou; Hui-Yu Bai; Bao-Shuai Shan; Akinori Higaki; Masaki Mogi; Masatsugu Horiuchi
Journal:  J Neuroinflammation       Date:  2020-04-07       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.